Joy Chen

Joy Chen has extensive work experience in the biopharmaceutical industry. Joy began their career at OncoMed Pharmaceuticals in 2011 as a Senior Scientist, where they worked until 2016. Following that, they joined Sutro Biopharma, Inc. as a Group Leader from 2016 to 2018. Currently, Joy is employed at Nektar Therapeutics, where they have held multiple roles. Joy started as a Senior Scientist from 2018 to 2019, then was promoted to Senior Scientist II in 2020, and is currently serving as an Associate Director since January 2021.

From 2005 to 2011, Joy Chen pursued their Doctor of Philosophy (PhD) degree at the University of California, Davis. The specific field of study is not provided.